CN Patent

CN115867271A — 术后恶心和呕吐的疗法

Assigned to Acacia Pharma Ltd · Expires 2023-03-28 · 3y expired

What this patent protects

氨磺必利可用于治疗(特别是预防)患者的术后恶心和/或呕吐(PONV)，特别是其中患者的BMI高(≥30)和/或患者为减肥手术患者。

USPTO Abstract

氨磺必利可用于治疗(特别是预防)患者的术后恶心和/或呕吐(PONV)，特别是其中患者的BMI高(≥30)和/或患者为减肥手术患者。

Drugs covered by this patent

Patent Metadata

Patent number
CN115867271A
Jurisdiction
CN
Classification
—
Expires
2023-03-28
Drug substance claim
No
Drug product claim
No
Assignee
Acacia Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.